List of works - Valerie J Waters

1256. New Acquisitions of ET-12 Burkholderia cenocepacia in Adults With Cystic Fibrosis: Role of Whole Genome Sequencing in Outbreak Investigation

scholarly article by Ana C Blanchard et al published November 2018 in Open Forum Infectious Diseases

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms

scientific article published on 26 October 2015

Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms

scientific article published in Scientific Reports

Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions

scientific article

Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections

scientific article

Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi

scientific article

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

scientific article (publication date: 3 December 2014)

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

scientific article

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

scientific article (publication date: 11 July 2012)

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

scientific article published on 19 December 2016

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

scientific article published on 10 June 2020

Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices

scientific article published on 31 October 2019

Antimicrobial resistance: Concerns of healthcare providers and people with CF

scientific article published on 17 June 2020

Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients

scientific article published on 7 January 2013

Burkholderia cenocepacia ET12 transmission in adults with cystic fibrosis

scientific article published on 15 November 2019

Burkholderia multivorans septicemia in a pediatric liver transplant patient

scientific article published on 05 September 2018

Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report

scientific article published on July 2008

Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.

scientific article

Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis

scientific article published on 16 August 2011

Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients

scientific article published on 5 January 2013

Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.

scientific article published on 13 April 2017

Clinical Outcomes Associated with Burkholderia cepacia Complex Infection in Patients with Cystic Fibrosis

scientific article published on 17 July 2020

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis

scientific article (publication date: 2 November 2015)

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis

scientific article

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis

scientific article published on 15 May 2020

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.

scientific article published on 19 June 2017

Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment

scientific article published on 7 March 2018

Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients

scientific article published on 2 November 2015

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis

scientific article published in December 2011

Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.

scientific article published on 18 August 2016

Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis.

scientific article published on 9 February 2017

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis

scientific article published on 3 October 2013

Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population

scientific article published on 01 July 2018

Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in Pediatric Cystic Fibrosis

scientific article published on 17 February 2011

Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.

scientific article published on 14 February 2015

Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis

scientific article published on 07 November 2020

Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients

scientific article published on 10 June 2013

Finding the relevance of antimicrobial stewardship for cystic fibrosis

scientific article published on 29 February 2020

Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis

scientific article published in 2022

In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients

scientific article published on 27 October 2014

Infections With Biofilm Formation: Selection of Antimicrobials and Role of Prolonged Antibiotic Therapy

scientific article published on 15 March 2016

Inhaled liposomal amikacin.

scientific article published on 31 May 2014

Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature ⬇️

scientific article published on February 1, 2011

Is there a role for antimicrobial stewardship in cystic fibrosis?

scientific article published on September 2014

Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.

scientific article published on 23 June 2016

Lung Clearance Index to Track Acute Respiratory Events in School-age Children with Cystic Fibrosis

scientific article published on 08 October 2020

MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections

scientific article published on 18 September 2017

Microbiology of Cystic Fibrosis Airway Disease

scientific article published on 30 December 2019

Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.

scientific article published on October 2006

Oral Azithromycin and Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis

scientific article published on 01 July 2019

Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams

scientific article published on 19 January 2019

Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients

scientific article published on 19 April 2007

Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis

scientific article published on 5 June 2015

Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection.

scientific article published on 2 March 2017

Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.

scientific article published on February 2014

Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.

scientific article

Pseudomonas aeruginosa strain sharing in early infection among children with cystic fibrosis

scientific article published on 16 June 2020

Pulmonary Exacerbations in Children with Cystic Fibrosis

scientific article

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

scientific article published on 14 December 2020

Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients.

scientific article published on 30 October 2014

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis ⬇️

scientific article published on May 10, 2012

Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species

scientific article published on 23 April 2012

Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis

scientific article

Sputum induction in routine clinical care of children with cystic fibrosis

scientific article published on 14 July 2010

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

scientific article

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

scientific article (published 2012-11-14)

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

scientific article (publication date: 7 December 2011)

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

scientific article published on 10 June 2020

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

scientific article published on 5 October 2017

Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.

scientific article published in October 2010

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

scientific article published on 16 July 2020

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

scientific article published on 14 December 2016

List of works by Valerie J Waters

1256. New Acquisitions of ET-12 Burkholderia cenocepacia in Adults With Cystic Fibrosis: Role of Whole Genome Sequencing in Outbreak Investigation

Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms

Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms

Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions

Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections

Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices

Antimicrobial resistance: Concerns of healthcare providers and people with CF

Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients

Burkholderia cenocepacia ET12 transmission in adults with cystic fibrosis

Burkholderia multivorans septicemia in a pediatric liver transplant patient

Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: a case report

Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.

Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis

Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients

Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.

Clinical Outcomes Associated with Burkholderia cepacia Complex Infection in Patients with Cystic Fibrosis

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.

Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment

Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis

Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis.

Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis.

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis

Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population

Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in Pediatric Cystic Fibrosis

Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.

Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis

Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients

Finding the relevance of antimicrobial stewardship for cystic fibrosis

Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis

In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients

Infections With Biofilm Formation: Selection of Antimicrobials and Role of Prolonged Antibiotic Therapy

Inhaled liposomal amikacin.

Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature ⬇️

Is there a role for antimicrobial stewardship in cystic fibrosis?

Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.

Lung Clearance Index to Track Acute Respiratory Events in School-age Children with Cystic Fibrosis

MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections

Microbiology of Cystic Fibrosis Airway Disease

Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.

Oral Azithromycin and Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis

Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams

Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients

Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis

Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection.

Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.

Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.

Pseudomonas aeruginosa strain sharing in early infection among children with cystic fibrosis

Pulmonary Exacerbations in Children with Cystic Fibrosis

Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software

Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients.

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis ⬇️

Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species

Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis

Sputum induction in routine clinical care of children with cystic fibrosis

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.

Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model